Ranbaxy Laboratories

Ranbaxy Laboratories

Dhiraj Singh/Bloomberg

The Ranbaxy Laboratories Ltd. logo is displayed on the side of a bottle. Ranbaxy is pulling back pills in 64,626 bottles of atorvastatin calcium in the U.S. after a “product complaint” was received by a pharmacist, the U.S. Food and Drug Administration said on its website.